Science & Enterprise subscription

Follow us on Twitter

  • A New England hospital system is assessing with real patients a point-of-care test for Covid-19 viruses that return… https://t.co/kdaawxTrOU
    about 8 hours ago
  • New post on Science and Enterprise: Hospitals Testing Fast Covid-19 Diagnostic https://t.co/Ou6Fk0L4Yb #Science #Business
    about 8 hours ago
  • Results of a clinical trial show contact lenses that focus light on multiple areas of the retina reduce near-sighte… https://t.co/fJkqvINR8w
    about 15 hours ago
  • New post on Science and Enterprise: Muti-Focus Contact Lenses Slow Children’s Myopia https://t.co/mWV1LNbHOW #Science #Business
    about 15 hours ago
  • Could?? ... How Russia’s Rushed Covid-19 Vaccine Could Backfire https://t.co/Sqt4P3jllE
    about 18 hours ago

Please share Science & Enterprise

A.I. Discovery Company Raises $123M in Venture Funds

Synthetic biology

A company using image analysis and deep learning to discover therapies for diseases often considered difficult to treat is raising $123 million in new venture funds. . . . → Read More: A.I. Discovery Company Raises $123M in Venture Funds

Start-Up to Engineer T-Cells for Autoimmune Diseases

Human T-cell

GentiBio Inc., a new enterprise in Boston, is starting work on creating engineered T-cells from the immune system to treat autoimmune diseases. . . . → Read More: Start-Up to Engineer T-Cells for Autoimmune Diseases

Venture Fund Plans $350M for Biotech Start-Ups

Investment graphic

A new venture fund plans investments in early-stage life science companies addressing critical needs in therapeutics, but also agriculture and industrial biotechnology. . . . → Read More: Venture Fund Plans $350M for Biotech Start-Ups

New Allergy Biotech Launches, Raises $10M

Peanutes in shells

A new company developing treatments to relieve allergic reactions with reprogrammed antibodies began work and is raising $10 million in its first venture funding round. . . . → Read More: New Allergy Biotech Launches, Raises $10M

Neuro Disease Start-Up Raises $73M in Early Funds

Neuron

A company developing new therapies for neurodegenerative diseases officially began operations, staked to $73 million raised in its first venture round. . . . → Read More: Neuro Disease Start-Up Raises $73M in Early Funds

Synthetic Protein Maker Raises $91.3M in Venture Funds

Elastapure bottle

A company creating animal-free designer proteins for skin care products is raising more than $91 million in its second venture funding round. . . . → Read More: Synthetic Protein Maker Raises $91.3M in Venture Funds

Venture Funding Down in 2020, Life Sciences Stay Hot

Seed and angel investing

For the first half of 2020, venture investing declined compared to 2019, but life science and biotechnology investments continued growing for the year. . . . → Read More: Venture Funding Down in 2020, Life Sciences Stay Hot

Start-Up Developing Inside-Cell Delivery, Gains $28.5M

Vesicles

A new company spun-off from Harvard University is developing techniques for delivering advanced genetic and protein therapies directly inside cells. . . . → Read More: Start-Up Developing Inside-Cell Delivery, Gains $28.5M

Gene Therapy Production Company Opens, Raises $40M

Adeno-associated virus

A new enterprise developing and manufacturing gene therapies, both its own and for others, is underway, raising $40 million in venture funds. . . . → Read More: Gene Therapy Production Company Opens, Raises $40M

Investment Funds Named for Underserved Entrepreneurs

Investing monitor

A foundation project identified its first five investment funds providing capital for start-up businesses founded by people usually overlooked by venture investors. . . . → Read More: Investment Funds Named for Underserved Entrepreneurs